Search the Newsreel

Ideal Power Inc (IPWR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Ideal Power Inc (IPWR), listing major individual and institutional holders, their proportional ownership, and recent changes in their holdings. It also categorizes shareholders by type and provides a historical overview of institutional shareholding data. The content includes …

AMTD IDEA Group (AMTD) Valuation: PE, PB & Fair Value Analysis

The AMTD IDEA Group (AMTD) has a current valuation score of 9.67, placing it 6th out of 118 companies in the Investment Banking & Investment Services industry. Its P/E ratio stands at 1.14, significantly lower than its recent high but slightly above its recent …

AMDQ5098190 Bond Risk Profile

This page provides a bond risk profile for AMDQ5098190, issued by AMTD IDEA Group. It highlights key metrics for credit risk assessment, including security level and issuer rating. The platform also offers access to exclusive analyst ratings for bonds.

IDEAL HOLDINGS S.A. Revenue Breakdown – ATHEX:INTEK

IDEAYA Biosciences Inc (IDYA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a brief overview of IDEAYA Biosciences Inc (IDYA)'s financial data, focusing on its revenue breakdown. It notes that detailed segment and regional revenue data has not yet been disclosed by the company. The available information indicates a reported revenue of $218.71M …

AMDQ5098190 Bond Redemption Profile

This article provides a bond redemption profile for AMDQ5098190, issued by AMTD IDEA Group. It explains what a bond redemption is and highlights key details such as the redemption type, date, amount, and the impact of a sinking fund schedule. The article informs users …

IDEAYA Biosciences Inc (IDYA) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health analysis of IDEAYA Biosciences Inc (IDYA), indicating a current financial score of 5.99, ranking 302 out of 386 in its industry. The company's financial status is stable, but its operating efficiency is low, with several key financial metrics …

IDEAYA Biosciences Inc (IDYA) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis of IDEAYA Biosciences Inc (IDYA), noting its current valuation score of 8.91 and ranking within the Biotechnology & Medical Research industry. It details the company's current P/E ratio, highlighting its position relative to recent highs and lows. The …

Ideal Power (NASDAQ:IPWR) Stock Price Passes Below 200 Day Moving Average - What's Next?

Ideal Power (NASDAQ:IPWR) shares recently fell below their 200-day moving average, trading at $3.98 with a volume of 75,111 shares. The company has a consensus "Hold" rating from analysts, with one buy and one sell rating, and an average target price of $10.75. Ideal …

IDEAYA Biosciences Inc (IDYA) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of IDEAYA Biosciences Inc (IDYA), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. As of July 24, 2026, the stock's price momentum score is 3.63, suggesting suitability for range-bound swing …

IPWR|Ideal Power Inc|Price:3.935|Chg%:-0.045

This article provides a comprehensive stock analysis of Ideal Power Inc (IPWR) by TradingKey, highlighting its healthy fundamentals, high growth potential, and "fairly valued" status within the Semiconductors & Semiconductor Equipment industry. The company, which specializes in bidirectional semiconductor power switches (B-TRAN technology), has …

IDYA|IDEAYA Biosciences Inc|Price:35.380|Chg%:-0.850

This article provides a detailed financial overview of IDEAYA Biosciences Inc (IDYA), including its income statement, balance sheet, and cash flow statement. It highlights key financial indicators, earnings history, and analyst ratings, presenting data up to FY2026Q1 and addressing frequently asked questions about the …

AMTD IDEA Group Revenue Breakdown – NYSE:AMTD

The article provides a breakdown of AMTD IDEA Group's revenue, highlighting that the largest contribution came from Southeast Asia, accounting for $28.36 million USD last year. It presents key financial data and segments related to the company's performance. The information is sourced from TradingView, …

AMTD|AMTD IDEA Group|Price:0.786|Chg%:-0.012

This article provides a comprehensive stock analysis of AMTD IDEA Group (AMTD) by TradingKey. It highlights the company's weak fundamentals and high growth potential, classifying its valuation as "fairly valued" within the Investment Banking & Investment Services industry. The report also notes high institutional …

AMTD|AMTD IDEA Group|Price:0.798|

AMTD IDEA Group (AMTD) has a share price of $0.798, with weak fundamentals and high growth potential, though its valuation is considered fair within its industry. The company has seen a significant decline in stock performance over the past month and year. Institutional ownership …

Ideal Power Inc (IPWR) Valuation: PE, PB & Fair Value Analysis

This article analyzes the valuation of Ideal Power Inc (IPWR) within the Semiconductors & Semiconductor Equipment industry, presenting its current valuation score and P/E ratio. The company's valuation score is 8.35, ranking 45 out of 105 in its industry, while its P/E ratio stands …

ETFs Investing in IDEAYA Biosciences, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of IDEAYA Biosciences, Inc. (IDYA). It provides a detailed table of these funds, including their market value, weight of IDYA in their holdings, issuer, management style, focus, expense ratio, assets under management (AUM), …

Enterprise value to revenue forward of Ideal Power Inc. – FWB:5ILA

This article displays the "Enterprise value to revenue forward" for Ideal Power Inc. (FWB:5ILA) on the Frankfurt Stock Exchange, as tracked on TradingView. It indicates that the market is currently closed with no trades recorded for this specific metric. The content focuses on financial …

Ideal Power Inc. SEC Filing (Jul 20, 2026)

This article reports on an SEC filing from Ideal Power Inc. (IPWR) on July 20, 2026. The filing is a Notice of Effectiveness for an S-3 shelf registration statement, which became effective on July 17, 2026, at 4:00 P.M. The article also provides recent …

IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs

IDEAYA Biosciences announced it will present three abstracts at the 2026 European Society of Medical Oncology (ESMO) meeting, showcasing updated data from its darovasertib clinical trials for uveal melanoma (OptimUM-02, OptimUM-01, OptimUM-09). Additionally, its partner Hengrui Pharma will present long-term results from the Phase …

Price to sales forward of Ideal Power Inc. – NASDAQ:IPWR

This page provides information on the price-to-sales forward ratio for Ideal Power Inc. (NASDAQ: IPWR). It displays financial data and other related information for the company on the TradingView platform. The content is primarily a data page with minimal descriptive text.

How Ideaya Biosciences Inc. (IDYA) Affects Rotational Strategy Timing

Ideaya Biosciences Inc. (IDYA) shows a weak near-term sentiment but strong long-term potential, according to AI models. The analysis identifies a mid-channel oscillation pattern and offers three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles. These strategies include specific …

IDEAYA melanoma data and partner Hengrui's lung cancer results head to ESMO

IDEAYA Biosciences (NASDAQ: IDYA) announced that three darovasertib abstracts and one IDE849 abstract have been accepted for poster presentation at the ESMO 2026 Congress, to be held in Madrid, Spain. The presentations will cover updates from multiple uveal melanoma trials, including registrational and neoadjuvant …

AMTD IDEA Group American Depositary Shares, each representing six (6) Class A Ordinary Shares (AMTD) Financials

This article provides comprehensive financial data for AMTD IDEA Group (AMTD), including annual income statements, cash flow statements, balance sheets, and key financial ratios from 2017 to 2025. It highlights trends in net income, operating income, revenue, debt, cash, and book value per share. …

AMTD Announces Positive Revenue Alert in 1H 2026, attributable to increased contributions from the Hospitality Arm through Successful Acquisitions of 4 Hotels

AMTD Q4 2020 Earnings: EPS Beat Surprises, But Stock Slips 3% - Revenue Growth Report

AMTD Digital Inc. (NYSE: HKD) unit TGE starts US$10M buyback and 2-year lock-up

AMTD Q4 2020 Earnings: Strong EPS Beat Amid Market Uncertainty - Estimate Uncertainty

AMTD IDEA Group American Depositary Shares, each representing six (6) Class A Ordinary Shares (AMTD) 10K Form and Latest SEC Filings 2026

AMTD Digital’s TGE Closes US$69 Million Tribeca Hotel Acquisition and Rebrands as AMTD IDEA Tribeca Hotel

With TGE Consolidated, AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

Pengendali Ini Rajin Borong Saham Idea Indonesia (IDEA), Ada Apa?

China's Midea Real Estate shares soar on property development spinoff

Chinese developer Midea Real Estate’s shares surge 100% on spin-off plan

21,000% surge of little-known AMTD Digital is latest meme stock craze, analyst says - ABC News

Alokasikan Laba Ditahan, Idea Indonesia Siap Ekspansi di 2022